Search results
Results from the WOW.Com Content Network
Allergies trigger your mucus membranes to produce histamines, which cause your cells to make even more phlegm. Taking an antihistamine will help stop excess fluid production. (Yes, your allergies ...
Dorzolamide, sold under the brand name Trusopt among others, is a medication used to treat high pressure inside the eye, including in cases of glaucoma. [3] It is used as an eye drop. [3] Effects begin within three hours and last for at least eight hours. [3] It is also available as the combination dorzolamide/timolol. [3] [4]
Ambroxol is available as syrup, tablets, pastilles, dry powder sachets, inhalation solution, drops and ampules as well as effervescent tablets. Ambroxol also provides pain relief in acute sore throat. Pain in sore throat is the hallmark of acute pharyngitis. [3] Sore throat is usually caused by a viral infection. The infection is self limited ...
This induces vasoconstriction of the blood vessels in the nose, throat, and paranasal sinuses, which results in reduced inflammation and mucus formation in these areas. Decongestant nasal sprays and eye drops often contain oxymetazoline and are used for topical decongestion .
Chest congestion is usually caused by excess mucus in the airways, says Meilan King Han, M.D., M.S., professor of medicine and chief of the Division of Pulmonary and Critical Care at the ...
Oxymetazoline, sold under the brand name Afrin among others, is a topical decongestant and vasoconstrictor medication. It is available over-the-counter as a nasal spray to treat nasal congestion and nosebleeds, as eye drops to treat eye redness due to minor irritation, and (in the United States) as a prescription topical cream to treat persistent facial redness due to rosacea in adults.
Along with a runny nose and sore throat, green phlegm is another cold-like symptom of COVID-19. Interestingly, the color of the mucus is an important indicator when it comes to infection.
Visine (/ ˌ v aɪ ˈ z iː n /), also known as Vispring, is a brand of eye drops produced by Kenvue. [1] Visine was first introduced in 1958 and was acquired by Pfizer in 1999. [2] [3] In 2006, Johnson & Johnson acquired Visine, along with Pfizer's entire consumer healthcare portfolio. [4]